LMG Life Sciences, the definitive guide to leading North American law firms and lawyers specializing in the life sciences industry, again recommends the firm’s Hatch-Waxman Patent Litigation (Generic) practice and names four Rothwell Figg attorneys, E. Anthony Figg ("Tony"), Steven Lieberman, Joseph Hynds ("Joe"), and R. Danny Huntington, Life Sciences Stars in Intellectual Property. Firms and attorneys included in the 2021 guide are ranked based upon three key criteria: case evidence, peer feedback, and client feedback.
Tony has been a Life Sciences Star since 2013 and is recognized for General Patent Litigation and Hatch-Waxman Patent Litigation in the 2021 rankings. He was shortlisted for Patent Strategy Attorney of the Year in the D.C. Metro area in the 2021 annual LMG Life Sciences Americas Awards. In 2018, he was inducted into the LMG Life Sciences Hall of Fame for his remarkable achievements in the industry. Tony specializes in intellectual property law, primarily involving the chemical, pharmaceutical, health care, and biotechnology industries. His practice focuses on patent litigation and inter partes matters before the PTAB, appeals, ADR, patent procurement, intellectual property licensing and related contract matters, opinions, and counseling.
Steven is recognized for Patent Strategy & Management, General Patent Litigation, and Hatch-Waxman Patent Litigation. He has been litigating patent and other intellectual property cases since 1991, and he has served as lead counsel in numerous lawsuits in the pharmaceutical, biotech, veterinary, and medical products fields, including handling more than 30 Hatch-Waxman litigations. Steve has experience representing both generic and brand name companies across district courts, the Federal Circuit, and the International Trade Commission. He also regularly advises clients on biosimilar issues and represents clients in IPR proceedings.
Joe, recognized for Hatch-Waxman Patent Litigation, has been practicing across the full spectrum of IP law at Rothwell Figg for over 25 years, with a focus on patent infringement litigation. He has particular expertise in Hatch-Waxman litigation and related issues, having litigated numerous cases and in many, serving as lead counsel. He also has participated in numerous appeals to the U.S. Court of Appeals for the Federal Circuit. Joe handles cases covering a broad range of pharmaceutical, medical device, biotechnology, and chemical technologies, among others.
Danny is recognized in the 2021 rankings in the practice areas of General Patent Litigation, Patent Prosecution, and Patent Strategy & Management. Danny is involved in all phases of intellectual property law, including U.S. and foreign patent prosecution, litigation in the federal and state courts, licensing, and general client counseling. He has extensive patent interference experience, with particular experience in biotechnology and pharmaceuticals.
To learn more about LMG Life Sciences rankings, and to view the full 2021 firm and attorney rankings, please visit www.LMGLifeSciences.com.